Clinical Trial Update: NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)

View source ↗

Summary

The NAC-003 P.L.U.S. Program clinical trial sponsored by Pamlab, Inc. has completed, evaluating effects in mild cognitive impairment, early memory loss, Alzheim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Vascular Dementia

Snippet

Sponsor: Pamlab, Inc. | Conditions: Early Memory Loss, Mild Cognitive Impairment | Status: COMPLETED